Lv1
50 积分 2026-03-08 加入
ZUP1 promotes DNA repair and immune evasion to drive olaparib resistance in triple-negative breast cancer
28天前
已完结
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA -mutant breast cancer
1个月前
已完结
Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade
2个月前
已完结